128 related articles for article (PubMed ID: 3026107)
21. Herpes simplex virus type 2 and cervical cancer.
Aurelian L
Clin Dermatol; 1984; 2(2):90-9. PubMed ID: 6100718
[No Abstract] [Full Text] [Related]
22. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type 2 and cervical cancer.
Rapp F
Curr Probl Cancer; 1981 Oct; 6(4):1-18. PubMed ID: 6271502
[No Abstract] [Full Text] [Related]
25. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.
Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J
Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842
[TBL] [Abstract][Full Text] [Related]
26. Prospects for control of herpes simplex virus disease through immunization.
Stanberry LR; Cunningham AL; Mindel A; Scott LL; Spruance SL; Aoki FY; Lacey CJ
Clin Infect Dis; 2000 Mar; 30(3):549-66. PubMed ID: 10722443
[TBL] [Abstract][Full Text] [Related]
27. The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial.
Skinner GR; Turyk ME; Benson CA; Wilbanks GD; Heseltine P; Galpin J; Kaufman R; Goldberg L; Hartley CE; Buchan A
Med Microbiol Immunol; 1997 Jun; 186(1):31-6. PubMed ID: 9255764
[TBL] [Abstract][Full Text] [Related]
28. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
[TBL] [Abstract][Full Text] [Related]
29. [Serological aspects of the relation between herpes virus and cervico-uterine cancer].
Suárez M; Del Campo G; Ojeda JM
Rev Chil Obstet Ginecol; 1983; 48(1):11-5. PubMed ID: 6099904
[No Abstract] [Full Text] [Related]
30. Control of herpes simplex virus infections of the genital tract by vaccination.
Buchan A; Skinner GR; Fuller A; Hartley C; Hallworth J; Stocker D; Melling J; Wiblin C
Vaccine; 1985 Mar; 3(1):49-53. PubMed ID: 4002836
[TBL] [Abstract][Full Text] [Related]
31. [Herpes simplex virus type 2 infection. Etiology, clinical aspects, diagnosis, therapy, HSV-2 and cervix cancer].
Kunkel M; Oberender H
Zentralbl Gynakol; 1985; 107(24):1473-8. PubMed ID: 3004067
[TBL] [Abstract][Full Text] [Related]
32. Herpes simplex virus vaccines.
Meignier B; Roizman B
Antiviral Res; 1985; Suppl 1():259-65. PubMed ID: 3002260
[No Abstract] [Full Text] [Related]
33. Hypothetical vaccination of the Dutch population with a herpes simplex virus vaccine: estimation of the profitability using a demographic projection model.
Bos CA
Vaccine; 1988 Aug; 6(4):309-14. PubMed ID: 2847437
[TBL] [Abstract][Full Text] [Related]
34. Effect of prior immunization on induction of cervial cancer in mice by herpes simplex virus type 2.
Wentz WB; Heggie AD; Anthony DD; Reagan JW
Science; 1983 Dec; 222(4628):1128-9. PubMed ID: 6316503
[TBL] [Abstract][Full Text] [Related]
35. [Genital herpes and cervical cancer].
Posevaia TA; Barinskiĭ IF
Vopr Virusol; 1983; 28(5):518-30. PubMed ID: 6197814
[No Abstract] [Full Text] [Related]
36. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease.
Kriesel JD; Spruance SL; Daynes RA; Araneo BA
J Infect Dis; 1996 Mar; 173(3):536-41. PubMed ID: 8627014
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection.
Erturk M; Phillpotts RJ; Welch MJ; Jennings R
Vaccine; 1991 Oct; 9(10):728-34. PubMed ID: 1661978
[TBL] [Abstract][Full Text] [Related]
38. Failure to induce cervical cancer in mice by long-term frequent vaginal exposure to live or inactivated herpes simplex viruses.
Meignier B; Norrild B; Thuning C; Warren J; Frenkel N; Nahmias AJ; Rapp F; Roizman B
Int J Cancer; 1986 Sep; 38(3):387-94. PubMed ID: 3017867
[TBL] [Abstract][Full Text] [Related]
39. [Viral infection and cervix carcinoma].
Schneweis KE
Gynakologe; 1984 Jun; 17(2):84-7. PubMed ID: 6088372
[No Abstract] [Full Text] [Related]
40. Herpes simplex virus glycoprotein treatment of recurrent genital herpes.
Stanberry LR; Burke R; Myers MG
J Infect Dis; 1988 Jan; 157(1):156-63. PubMed ID: 2826603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
